512 On Other Exchanges
Hong Kong
text size: T | T
Back to Snapshot
Company Description

Contact Info

The Center

Units 3302

33rd Floor

99 Queen’s Road


Hong Kong



China Grand Pharmaceutical and Healthcare Holdings Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations, pharmaceutical intermediates, specialized pharmaceutical raw materials, and healthcare products. The company offers pharmaceutical preparations, such as cerebro-cardiovascular, ophthalmic gel and eye drops, antibacterial, antibiotics, and antipyretics and analgesic; and active pharmaceutical ingredients (APIs), which include amino acids, analgin, and metronidazole. It also provides steroid hormones APIs and its intermediates, including glucocorticoid and sex hormones. In addition, the company offers Taurine, an organic amino acid that is used to enhance immunity system, increase level of cell differentiation, growth, and supplement in infant milk powder, as well as used in energy drinks and in treatment of certain heart diseases. Further, it manufactures ophthalmic medical devices and surgical supplies; and provides agricultural chemicals comprising bio-pesticides, biocides, and bio-feed additives; and fine chemicals, such as calcium superphosphate and dimethyl sulfate. China Grand Pharmaceutical and Healthcare Holdings Limited operates primarily in the People’s Republic of China, as well as in the United States, Europe, Asia, and internationally. The company was incorporated in 1995 and is based in Central, Hong Kong. China Grand Pharmaceutical and Healthcare Holdings Limited is a subsidiary of Outwit Investments Limited.


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

512 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 512.
View Industry Companies

Industry Analysis


Industry Average

Valuation 512 Industry Range
Price/Earnings 16.1x
Price/Sales 0.9x
Price/Book 2.5x
Price/Cash Flow 16.3x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CHINA GRAND PHARMACEUTICAL A, please visit www.chinagrandpharm.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.